Objective. The University of Chicago Medicine (UCM) led the Expanded Testing and Linkage to Care (X-TLC) program for disproportionately affected populations on the South Side of Chicago. The X-TLC program aimed to expand routine HIV testing to high-prevalence communities with disproportionately affected populations (i.e., minority men and women, men who have sex with men, and intravenous drug users) according to CDC guidelines at multiple clinical sites.
Until recently, the incidence of new human immunodeficiency virus (HIV) infections in the United States had remained constant since the early 1990s, with 56,000 people becoming infected each year and the number of people living with HIV/acquired immunodeficiency syndrome (AIDS) continuing to increase. 1 To avoid further challenges with treating more people with HIV and higher health-care costs, the White House Office of National AIDS Policy developed the National HIV/AIDS Strategy. 2 This strategy provided a roadmap for the Centers for Disease Control and Prevention's (CDC's) Expanded HIV Testing for Disproportionately Affected Populations program and the Chicago, Illinois, Enhanced Comprehensive HIV Prevention Plan. 3 Since implementation, Chicago has seen a decline in new HIV infections and new AIDS diagnoses. 4 Recent progress in expanded routine testing, the dramatic effect of antiretroviral therapy on viral load, HIV treatment as prevention, pre-exposure prophylaxis, and other prevention measures make the goal of reducing or even eliminating new HIV infections a real possibility. [5] [6] [7] While the city has made progress, not everyone has benefited. African American and Hispanic people have disproportionately higher rates of new HIV infection and AIDS diagnoses than those who self-identify as white. While new HIV infections in Chicago are declining, new infections among young men who have sex with men (MSM) have increased by 5% since 2007. 4 Preventing HIV transmission in this group and other high-risk groups requires outreach using social and sexual network methodology, as well as new behavioral and biomedical prevention interventions. HIV screening in health-care settings, however, remains important for identifying individuals unaware of their HIV infection and needing linkage to care and antiretroviral therapy. [8] [9] [10] [11] Nationally, our health-care system does a poor job of engaging HIV-infected individuals at all points of the care continuum. 12 In Chicago, too many people are still unaware that they are infected with HIV (e.g., an estimated 16% of people living with HIV/AIDS are undiagnosed), and only 61% of HIVinfected people are in care. 4 Despite the failures of targeted testing, some authorities still believe targeted testing might have advantages over universal screening. Haukoos and colleagues developed a prediction tool, the Denver HIV risk score, which was derived from patients seen in a public sexually transmitted disease clinic in Denver from January 1, 1996 , through December 31, 2008 . 13 This score was validated in a separate urban ED population in Cincinnati, Ohio, from January 1, 1998, through June 30, 2010, and did predict the probability of HIV infection on subsequent testing. Lyons and colleagues, however, compared fully implemented targeted testing with universal screening in a prospective, randomized study in the urban ED in Cincinnati from January 2008 through December 2010. 14 Targeted testing did not lead to a higher positivity rate or reduction in tests performed, and screening actually identified more cases. Uncertainty regarding best practices might also explain why few hospitals report that they conduct routine HIV screening, with failure to screen being common across all types of hospitals. 15 Routine HIV screening has been conducted in varying clinical venues using different testing methodologies (standard HIV testing vs. rapid point-of-care testing), different processes for obtaining patient consent (opt-in vs. optout), and different strategies for informing patients of their results and linking HIV-infected patients to care. In general, little evidence or data suggest that one universal screening strategy that incorporates a particular testing methodology, consenting process, or approach to test notification is superior to another with respect to uptake, linkage-to-care rates, clinical outcomes, or harms from screening, according to the systematic review conducted to update the U.S. Preventive Services Task Force recommendations. 16 Furthermore, although the sustainability of disparate models is unknown, running parallel programs with dedicated point-of-care HIV testers and/or patient navigators for linkage to care most likely costs more than incorporating HIV testing and linkage to care into routine medical care.
The Chicago Department of Public Health (CDPH) sponsors and oversees the Expanded Testing and Linkage to Care (X-TLC) for Disproportionately Affected Populations on the South Side of Chicago initiative at the University of Chicago Medicine (UCM) as part of the overall HIV prevention program for the city. This program is part of a CDC initiative that began in 2007 and has sponsored 25 health departments, including CDPH. CDPH-sponsored prevention sites conducted more than 68,000 HIV tests in Chicago in 2013; 70.0% of tests were conducted in clinical settings, and 63.0% of these tests were performed by the X-TLC program (Personal communication, Nanette Benbow, Chicago Deputy Commissioner, HIV/STI Services, August 2014).
Our program evaluated the number of HIV-infected individuals, the number notified of their test results and linked to care, and performance at other points in the HIV care continuum. We describe unique aspects of our program, including standard laboratory testing vs. rapid testing, test follow-up after clinical encounter vs. point-of-care testing, assigned responsibility for test notification and linkage to care, and the use of trained Expanded HIV Testing and Linkage to Care  109 Public Health Reports / 2016 Supplement 1 / Volume 131 social workers who are part of an HIV care program to assure linkage to care vs. a parallel process of dedicated testers or patient navigators.
METHODS

Purpose
The X-TLC program aimed to expand routine HIV testing to high-prevalence communities according to public health guidelines. As the lead organization, UCM provided oversight and support to other community sites to assist with the development and implementation of policies and procedures that would promote routine screening as outlined in CDC's 2006 recommendations. CDPH required all sites to provide care to the following populations that were disproportionately affected by HIV infection: (1) African American and Hispanic men and women and (2) MSM and injection drug users, regardless of race/ethnicity. CDPH's goal was to screen 97,000 individuals: 27,000 in the first year and 35,000 per year for the next two years. These goals were set forth by the funding agency, CDPH, in its request for applications and were in accordance with CDC's program for expanding testing for disproportionately affected populations.
Patient population
Chicago's South Side neighborhoods primarily comprise minority communities of color and shoulder a substantial portion of the HIV burden within the city. The overall HIV prevalence rate in Chicago is 799.6 people per 100,000 population (people with HIV through April 1, 2013, using 2010 U.S. Census data), 4 which is almost three times the national rate of 268.6 cases of HIV infection per 100,000 population (CDC HIV surveillance data through 2009). 16 Eleven of the 19 communities with the highest prevalence of people living with HIV (1,372-2,507 per 100,000 population) are within the X-TLC catchment area (supplemental data available upon request). While the payer mix varies widely across X-TLC sites, many sites act as primary health-care providers for uninsured and underinsured individuals in their communities (Table 1) .
Site selection
As part of the Urban Health Initiative at UCM, the South Side Health Collaborative comprises multiple providers that form a coordinated health-care network. All sites except Planned Parenthood of Illinois were recruited through this collaborative. The number of unique patients seen by each organization varied widely, and testing targets were selected based on patient census data (Table 1) .
Institutional policy changes
When the X-TLC program was proposed in November 2010, UCM adopted a new hospital policy promoting routine opt-out testing and eliminating written consent. In addition, ultimate responsibility for oversight of HIV screening, test notification, and linkage to care was assigned to the HIV Care Program at UCM. Partnering sites and UCM worked collaboratively to create policies and procedures modeled after UCM that would facilitate routine screening within their organizations. Institutional culture, provider comfort, and laboratory procedures were considered in the development of HIV testing policies at each site, and some sites, including the lead site, ultimately used an opt-in approach to assure that patients were aware they were being tested and could ask questions.
Consent procedures
Consent for HIV testing was obtained through opt-in oral consent at UCM and most other participating sites. Staff members at UCM and partnering sites preferred opt-in language, although policies allowed for the use of opt-out testing. Because Illinois statute requires evidence of oral consent for HIV testing in the patient's medical record, UCM and partnering sites included this record of oral consent in the patients' electronic medical records (EMRs). Additionally, several sites preferred to have brief pretest counseling with patients. UCM provided a patient education sheet discussing the rationale for screening, risk factors for HIV acquisition, and significance of the test result, whether it was positive or negative, for locations that did not provide oral pretest counseling. The sheet also provided a telephone number for the X-TLC program for further information and listed telephone numbers for testing information from the State of Illinois and CDC.
Testing methods
The test technologies used included standard thirdgeneration blood-based enzyme immunoassay and confirmatory Western blot or fourth-generation HIV testing with Multispot confirmation, depending on the site. Only Planned Parenthood used rapid pointof-care testing.
Information technology (IT) interventions
IT developments at UCM provided several solutions to common barriers to HIV screening. An electronic alert was implemented within the UCM EMR that fired when there was an encounter with an eligible patient who was aged 13-64 years and did not have a prior HIV antibody test result in the EMR. Physicians could order HIV antibody testing from the prompt or could The X-TLC program aimed to expand routine HIV testing to high-prevalence communities with disproportionately affected populations (minority men and women, men who have sex with men, and intravenous drug users) according to Centers for Disease Control and Prevention guidelines at multiple clinical sites in Chicago. As the lead organization, University of Chicago Medicine provided oversight and support to other community sites. b The total number of patients was not known. exit the alert if a patient declined or had not been offered testing. Across most sites, electronic orders also included HIV testing for different patient care settings. The electronic order required documentation that the patient gave oral consent to testing, eliminating the need for other notation in the EMR. Our alert did not have any hard stops, and alerts could be ignored. As such, we were unable to collect data on the number of tests offered, the number of patients who refused, and the number of patients previously tested elsewhere.
The variability of EMRs across sites made it difficult to implement solutions for all locations and to capture data on patients who were offered but declined testing.
Educational efforts
The X-TLC initiative was promoted to institutional leadership, providers, and staff members at all sites through a series of in-service meetings at multiple locations. Program presenters reviewed the 2006 CDC guidelines for HIV screening, discussed the rationale Expanded HIV Testing and Linkage to Care  111 Public Health Reports / 2016 Supplement 1 / Volume 131 for universal HIV screening, presented local data on HIV testing at UCM, and discussed our local screening strategy. They also emphasized the failure of risk-based screening to identify a substantial proportion of people with HIV early in the course of their disease. Furthermore, presenters described the HIV test characteristics that made ideal screening tools and evaluated HIV testing according to accepted criteria recommended for any medical screening: (1) the condition is important, (2) the natural history is understood, (3) there are effective treatments, (4) early treatment is beneficial, and (5) the cost of testing is substantially lower compared with possible expenditures on medical care if diagnosis is delayed. 17 Presenters also discussed the cost-effectiveness of screening when HIV prevalence is .0.1% 18 and how screening benefits public health, because people who know their status are less likely to engage in high-risk behaviors that could transmit HIV to others.
Testing review, test notification, and linkage to care
Each week, the UCM linkage-to-care coordinator received an automated report of all patients tested for HIV. The coordinator reviewed the list to discuss active linkage to care for those with positive test results and supplemental or repeat testing for patients with indeterminate results. Coordinators at other sites regularly reviewed their own test results and linked patients to care. Although ordering providers were encouraged to discuss results with patients, the linkage-to-care coordinator at UCM notified HIV-positive patients if the site personnel were uncomfortable with test notification or unable to make contact. Patients without working telephone numbers were sent a generic letter requesting a return telephone call; those who did not respond were reported to CDPH for case finding.
Mercy Medical Center, UCM, ACCESS Community Health Network, and Friend Family Health Center provided on-site HIV specialty care and were the primary care sites for patients tested through the initiative. The UCM linkage-to-care coordinator provided support for linkage to care, regardless of testing location, and made recommendations based on patient insurance and citizenship status. A patient was considered linked to care if he or she attended at least one medical care appointment with an HIV care provider.
Site initiation and technical support
An initiation visit was conducted at each site to review contracting requirements, discuss goals, negotiate scopes, assess technical support needs, and schedule site trainings. Technical support included assistance with building reports from the EMR, drafting testing policies, and arranging training sessions for both clinical and nonclinical staff members with assistance from the Midwest AIDS Training and Education Center.
Data collection and statistical analysis
All sites used an EMR, and data abstraction occurred throughout the course of the program. It included the test date, site location, department, test result, patient demographics and (for people with reactive results only) patient name, prior visit date, previous HIV test result, department, CD41 count, viral load, medical appointment date, risk factor, and medical appointment attendance. Partnering sites were responsible for providing these data and tracking linkage-to-care and retention outcomes for patients who were linked to care sites outside the X-TLC care network. Identification of new vs. existing positive diagnoses was based on previous testing history within the agency (when possible) or self-reported patient testing history. Collected data were housed and updated in REDCap. 19 All data were analyzed using Stata ® . 20 One-way analysis of variance (ANOVA) was used to examine starting CD41 counts of patients newly diagnosed through each program year. One-way analyses of covariance (ANCOVA) were used to identify the effect of other covariates on the CD41 counts and the year of diagnosis. The analysis of early deaths (i.e., death within one year after a new diagnosis of HIV infection) was analyzed by Fischer's exact test. We considered p0.05 to be statistically significant.
RESULTS
The X-TLC program was conducted with UCM and nine community partner sites from February 1, 2011, through December 31, 2013. Upon completion of the X-TLC initiative, 75,345 HIV tests were performed ( Table 2 ). Some individuals had repeat testing, but the number of unique patients tested was 67,153 (data not shown). The number of tests represented only 77.7% of the planned number of tests (75,345/97,000 tests were anticipated), but testing increased each year (11, 839 tests in 2011, 27,265 tests in 2012, and 36,241 tests in 2013) without any incremental increase in funding. The majority of patients tested met program goals for testing disproportionately affected members of minority groups, although universal screening was the goal at all sites, regardless of population demographics. Of the 75,345 HIV tests, 48,044 (63.8%) were performed on patients who self-identified as African American, 11,833 (15.7%) on patients who self-identified as white, 2,343 (3.1%) on patients who reported other races, 6,606 (8.8%) on those who self-identified as Hispanic or Latino, and 13,131 (17.4%) on those whose race or ethnicity was not known. The proportion of tests performed on patients who self-identified as African American was even higher in EDs (11,054 of 12,957, 85.3%) than in other clinical settings. Women accounted for 54,560 (72.4%) tests.
Screening the 67,153 unique patients identified 395 HIV-infected patients for an overall seroprevalence of 0.6%. However, 127 of 12,957 patients tested in EDs were positive, for a seroprevalence of 1.0%. Of the 395 patients testing positive for HIV, 207 (52.0%) had been diagnosed previously, 176 (45.0%) were confirmed as new diagnoses, and 12 (3.0%) had an unknown prior status. The seroprevalence of undiagnosed cases of HIV was 0.3% (176/67,153), a substantial proportion and higher than the 0.1% cutoff for the seroprevalence accepted for cost-effective HIV screening. This seroprevalence did not vary substantially by site type: 62 of 28,574 (0.2%) HIV-positive tests at community health centers, 36 of 16,333 (0.2%) at community hospitals, and 78 of 30,438 (0.3%) at academic medical centers (calculated from data in Table 2 ). The seroprevalence for undiagnosed cases was higher at 63 of 12,957 (0.5%) patients tested in EDs compared with other health-care settings. The overall seroprevalence decreased, from 87 of 11,839 (0.7%) in 2011 to 134 of 27,265 (0.5%) in 2012 and 174 of 36,241 (0.5%) in 2013 (calculated from raw data in Table 2 ). The seroprevalence of previously undiagnosed HIV-infected individuals also decreased, from 32 of 11,839 (0.3%) in 2011 to 66 of 27,265 (0.2%) in 2012 and 76 of 36,241 (0.2%) in 2013 (calculated from raw data in Table 2 ). Of the 176 patients newly diagnosed with HIV infection, 142 (80.7%) self-identified as African American, 15 (8.5%) as white, 19 (10.8%) as either other (1.7%) or unknown (9.1%), and 11 (6.3%) as Hispanic (Table 3) . A total of 119 (67.6%) of new HIV diagnoses were men, 55 (31.3%) were women, and two (1.1%) were transgender. This proportion of women was higher than that reported for Chicago overall, where women accounted for 19.0% of HIV diagnoses in 2011 even though more than twice as many women were tested than men. 4 Risk factors for HIV acquisition were reported for 133 of 176 (75.6%) newly diagnosed patients. Of the 133 patients reporting mode of acquisition, 77 (58.6%) reported heterosexual exposure, 54 (40.6%) reported MSM, and nine (6.8%) reported intravenous drug use. The risk factors for acquisition in the X-TLC program were also quite different from the demographics of new HIV diagnoses in Chicago in 2011, with 694 of 1,008 (68.9%) newly diagnosed people acquiring HIV through MSM and 215 of 1,008 (21.3%) through heterosexual contact. 4 HIV screening in health-care settings identified patients who were not targeted for outreach HIV screening and prevention programs. The exception was screening in EDs, where MSM was the most common risk factor identified by 29 of 60 (48.4%) patients reporting risk factors.
Of the 176 patients who were newly diagnosed, three patients died before testing was completed and could not be notified, and 166 of the remaining 173 patients (96.0%) received their test results. Fifty of the 166 patients (30.1%) were notified by the linkage-to-care coordinator by phone, which was the most common 21 We did not have access to patient information for the 25 (17.0%) patients who were linked to 12 other sites, as our network of HIV physicians was not providing care for these patients and did not have access to clinical information after linkage.
Although the X-TLC program's primary goal was to identify patients unaware of their HIV infection, identifying patients with a prior diagnosis is another opportunity to capture patients who are out of care and relink them ( Table 4 ). Of the 207 patients previously diagnosed with HIV infection, 92 (44.0%) were confirmed to be in care and nine (4.0%) had moved or died. Of the remaining 106 (52.0%) patients not in care, 78 (73.0%) were relinked to care. Of the 70 previously diagnosed patients who were subsequently linked to care with a provider in our program, 50 (71.0%) began antiretroviral therapy and 35 (50.0%) had a suppressed viral load (calculated from data in Table 4 ).
We had baseline CD41 counts for 122 of the 176 newly diagnosed patients. Baseline CD41 counts at UCM have historically been 200 cells/cubic millimeter (mm 3 ); during X-TLC, baseline CD41 counts at UCM increased from 186 (95% CI 104, 268) cells/ mm 3 in 2011 to 316 (95% CI 222, 410) cells/mm 3 in 2012 to 494 (95% CI 384, 604) cells/mm 3 in 2013 (p50.09, ANOVA). Across all X-TLC sites, the baseline CD41 counts increased from 238 (95% CI 158, 318) cells/mm 3 in 2011 to 324 (95% CI 249, 399) cells/mm 3 in 2012 to 437 (95% CI 357, 517) cells/mm 3 in 2013 (p50.007, ANOVA) ( Table 5) .
A smaller proportion of patients were diagnosed at CD41 counts 200 cells/mm 3 during the three years of the program. We looked at other variables that might have affected the baseline CD41 count, including age, race, sex, risk factor for HIV acquisition, and type of health-care site. Women had higher baseline CD41 counts than men (mean 5 451329 cells/mm 3 vs. 311235 cells/mm 3 , respectively, p50.03 by ANOVA), and patients diagnosed at community health centers had higher CD41 counts (mean 5 460249 cells/mm 3 ) than patients diagnosed in the hospital setting (301205 cells/mm 3 for community hospitals and 31028 cells/mm 3 for the academic medical center, p50.02 by ANOVA). When we adjusted for these covariates, however, the year of diagnosis was still substantially associated with the baseline CD41 count (p50.02, ANCOVA), indicating earlier diagnosis of HIV infection throughout our program ( Table 5 ). The diagnosis of fewer patients with advanced disease (i.e., CD41 count 200 cells/mm 3 ; 11 in 2011, 14 in 2012, and 10 in 2013) ( Table 5) 
DISCUSSION
We described several unique aspects of the X-TLC initiative that increased the capacity for screening and linkage to care. First, the use of standard blood-based laboratory testing vs. point-of-care testing eliminated the need for a parallel process of care and made testing part of routine health care. Phlebotomy was available for all patients as part of routine medical care, so there was no limit to the number of tests that could be performed. Another unique aspect of the X-TLC program was the assignment of responsibility for oversight of HIV testing to the HIV Care Program at UCM. Previously, it was expected that the ordering physician was responsible for notification of test results. Making providers who have limited experience in conducting HIV pre-or posttest counseling or test result notification responsible for these activities is often a barrier to routine testing. Many physicians have little experience with providing results to patients who test positive, and they might be unable to discuss treatment options and linkage to care. Weekly electronic reports of HIV testing events helped our linkage-to-care coordinators actively follow up with individuals who tested positive.
The X-TLC program aimed to expand routine HIV testing to high-prevalence communities with disproportionately affected populations (minority men and women, men who have sex with men, and intravenous drug users) according to Centers for Disease Control and Prevention guidelines at multiple clinical sites in Chicago. As the lead organization, University of Chicago Medicine provided oversight and support to other community sites. Coordinators initially contacted the ordering physicians to see if they would notify the patients or if they wanted our group to do so. At the time of test notification, our coordinator was available for counseling and was able to immediately schedule a medical care visit with an experienced HIV care provider. With high patient volumes and high-risk patient populations, EDs are prime areas for screening. However, studies have revealed that missed opportunities for earlier diagnosis occur frequently in EDs. [22] [23] [24] Uptake of screening in ED settings has been limited due to the time and financial burdens imposed by testing programs. Giving the responsibility of notification and linkage to care to an HIV care program reduces the burden for an already over-tasked ED. Our ED providers elected to have our linkage-to-care coordinators contact all HIV-infected patients. This approach previously led to a substantial increase in ED testing at UCM, and this earlier success with our ED has been repeated with the X-TLC program. 25 Linking patients to care at the time of test notification worked extremely well, but it should be remembered that patients screened in this program were already engaged in care, with the possible exception of patients screened in the ED or in inpatient hospital units. It is clearly more difficult to link patients to care when they are tested in non-primary care settings. 26 The use of social workers who are trained to assess needs and help overcome barriers to linkage to care very likely positively affected our results. It is also an advantage to have the same group responsible for expanded HIV testing to also be involved in linkage to care and medical care. We have looked at the continuum of care cascade for patients with a new HIV diagnosis identified through the X-TLC program and linked to providers in our network, and have found that 63.0% have achieved a viral load 200 copies/ mL. This increased proportion of HIV patients with viral suppression is reducing the community viral load and preventing new transmissions.
Not only did our program have success in intermediate process outcomes (i.e., increased testing events and patients diagnosed with HIV and linked to care), but it also affected clinical outcomes. The earlier diagnosis, as evidenced by higher baseline CD41 counts in our program, is encouraging, as up until at least 2010, baseline CD41 counts in the United States had not changed since 1992. 27 Earlier diagnosis is extremely important for improving outcomes for patients infected with HIV. Patients with a late diagnosis of HIV have a substantial risk of AIDS and/or death in the first year after diagnosis. 28, 29 Long-term survival is also improved with earlier diagnosis. 30 Within our cohort, we have seen a reduction in early mortality within the first year after a new diagnosis when comparing years two and three with the first year of the program. It is possible that the lower baseline CD41 counts in the first year might represent more targeted testing early in the program and more screening in the latter part of the program. A change in physician behavior from targeted to routine screening is, however, exactly in line with the program's purpose. Although the identification of patients previously diagnosed with HIV infection was not the focus of our program, we believe that identifying patients who know they are HIV-infected but do not disclose their HIV positivity during the clinical encounter is another benefit of the universal testing approach. More than half (51.7%) of the patients testing positive in our program had a prior diagnosis. For whatever reason, they represented a group of patients that is very likely to be out of care. We were able to reconnect 72.9% of these patients to care. Identifying these individuals and linking them to care is extremely important, as 91.5% of new HIV transmissions are linked to people who are not in care, including 30.2% of transmissions from people who are undiagnosed and 61.3% of transmissions from people with known diagnosis who are not in care. 31 
Limitations
The X-TLC initiative was subject to several limitations. First, our program was far from achieving universal screening for all eligible patients. We might, however, have tested at a level that effectively identified a substantial proportion of patients with HIV who were unaware of their status. A recent study suggests that health-care systems should see a substantial decline in undiagnosed HIV patients if they annually reach 20% of their eligible population. 32 Interestingly, 59.0% of our newly diagnosed patients acquired HIV through heterosexual contact and 31.3% were women. Patients diagnosed through screening in health-care settings may not reflect the overall demographics of the HIV epidemic. Although our sites might care for more heterosexual men and women, it is also possible that heterosexual men and women were offered and/or accepted testing more frequently than MSM despite having a lower prevalence of HIV infection. The exception was ED screening, where MSM was the most com-mon risk factor identified at 48.4%, but this percentage was still lower than the proportion of cases acquired through MSM for Chicago (69.0%). Health-care screening programs may not reach high-risk populations such as young African American MSM. On the other hand, heterosexual men and women are not necessarily targeted for screening in outreach programs and may only be diagnosed by testing in health-care settings.
Changing provider behavior has been slow, even with champions promoting HIV in various clinical areas at UCM and at our community sites. Education has had limited impact. We have repeated our educational campaign many times for multiple groups at UCM and our other sites, with updates on our progress. To assess the impact of education, we have surveyed staff members in medicine, emergency medicine, pediatrics, and obstetrics and gynecology to assess knowledge, attitudes, and behaviors toward HIV screening. 33 Our data indicate that despite increased knowledge of current recommendations and positive perceptions of screening (e.g., believing it is good for patients and for public health), actual testing practices did not improve substantially.
Electronic alerts might be helpful, but alerts are frequently ignored. It would be helpful to have providerspecific data on how often testing is being offered, deferred, or refused by patients, and report individual performance as compared with that of peers and overall program goals. We reported our results to the Department of Medicine Safety Committee, highlighting the increased baseline CD41 counts for newly diagnosed HIV patients and the decrease in early deaths. This committee subsequently endorsed HIV screening as a quality performance measure for all physicians in the department. The designation as a quality performance measure could be the impetus that changes physician behavior to make HIV screening part of routine medical care. Although education did not change testing behaviors, it might have improved acceptance of new institutional requirements to test.
One problem with universal screening is that risk factor assessment might be deferred, making it difficult to identify patients who need repeat testing and/ or a referral to designated prevention programs for preexposure prophylaxis or behavioral interventions. We also need to develop systems to assure that patients who test negative for HIV are notified of their result. Posttest counseling for negative results is an opportunity to educate patients about avoiding HIV, and this patient encounter might also be an opportunity to identify high-risk patients who could benefit from repeat testing and/or prevention programs. Finally, we developed our HIV screening efforts independent Expanded HIV Testing and Linkage to Care  119 Public Health Reports / 2016 Supplement 1 / Volume 131 of other health screenings. In the future, we need to take a more coordinated approach to implementing all recommended health screenings for our patients (i.e., develop health screening care bundles).
CONCLUSION
We described our program for expanded HIV testing using conventional laboratory testing instead of pointof-care testing across a network of hospitals and healthcare centers, with responsibility for test notification and linkage to care assigned to the lead organization. This program has expanded testing and successfully linked patients to medical care with experienced HIV providers. Clinical outcomes were also improved, with diagnosis at an earlier stage of disease and a reduction in early mortality.
